Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
Colorcon
Boehringer Ingelheim
Chinese Patent Office
McKinsey
Federal Trade Commission
Merck
Moodys

Generated: June 23, 2018

DrugPatentWatch Database Preview

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydrocodone Polistirex And Chlorpheniramine Polistirex, and what generic alternatives are available?

Hydrocodone Polistirex And Chlorpheniramine Polistirex is a drug marketed by Tris Pharma Inc and is included in one NDA.

The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Summary for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Drug patent expirations by year for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Pharmacology for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Synonyms for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
131219-97-1
Chlorpheniramine / hydrocodone
Chlorpheniramine Mixture With Hydrocodone
Chlorpheniramine polistirex / Hydrocodone polistirex
Chlorpheniramine polistirex and Hydrocodone polistirex
DTXSID50156960
Hydrocodone conbination product 15 mg/du
S-T Forte 2
SCHEMBL2522788
Tussicaps
Tussicaps extended-release
Tussionex
Tussionex Pennkinetic
Tuzistra XR
Vituz

US Patents and Regulatory Information for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX chlorpheniramine polistirex; hydrocodone polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091632-001 Oct 1, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Daiichi Sankyo
Argus Health
Moodys
Julphar
Colorcon
Farmers Insurance
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.